Im, K.-I.; Kim, N.; Lee, J.; Oh, U.-H.; Lee, H.-W.; Lee, D.-G.; Min, G.-J.; Lee, R.; Lee, J.; Kim, S.;
et al. SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants. Int. J. Mol. Sci. 2024, 25, 10512.
https://doi.org/10.3390/ijms251910512
AMA Style
Im K-I, Kim N, Lee J, Oh U-H, Lee H-W, Lee D-G, Min G-J, Lee R, Lee J, Kim S,
et al. SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants. International Journal of Molecular Sciences. 2024; 25(19):10512.
https://doi.org/10.3390/ijms251910512
Chicago/Turabian Style
Im, Keon-Il, Nayoun Kim, Junseok Lee, Ui-Hyeon Oh, Hye-Won Lee, Dong-Gun Lee, Gi-June Min, Raeseok Lee, Jinah Lee, Seungtaek Kim,
and et al. 2024. "SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants" International Journal of Molecular Sciences 25, no. 19: 10512.
https://doi.org/10.3390/ijms251910512
APA Style
Im, K. -I., Kim, N., Lee, J., Oh, U. -H., Lee, H. -W., Lee, D. -G., Min, G. -J., Lee, R., Lee, J., Kim, S., & Cho, S. -G.
(2024). SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants. International Journal of Molecular Sciences, 25(19), 10512.
https://doi.org/10.3390/ijms251910512
